reserpine has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, JP; Khan, SM; Smith, TS | 1 |
Antonio, T; Dutta, AK; Ghosh, B; Kharkar, P; Reith, ME; Zhen, J | 1 |
2 other study(ies) available for reserpine and guanosine 5'-o-(3-thiotriphosphate)
Article | Year |
---|---|
Effects of single and multiple treatments with L-dihydroxyphenylalanine (L-DOPA) on dopamine receptor-G protein interactions and supersensitive immediate early gene responses in striata of rats after reserpine treatment or with unilateral nigrostriatal le
Topics: Animals; DNA-Binding Proteins; Dopamine Agents; Early Growth Response Protein 1; Gene Expression Regulation; Genes, Immediate-Early; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Immediate-Early Proteins; In Situ Hybridization; Levodopa; Male; Neostriatum; Oxidopamine; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Substantia Nigra; Sympatholytics; Transcription Factors; Zinc Fingers | 1999 |
Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal models.
Topics: Animals; Antiparkinson Agents; Benzothiazoles; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Free Radical Scavengers; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Isoquinolines; Locomotion; Mice; Parkinson Disease; Radioligand Assay; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Structure-Activity Relationship; Thiazoles | 2010 |